Top 10 Drug Delivery Solution Providers 2022

Drug delivery has become an important topic in the pharmaceutical industry over the last several decades because it has been discovered that a drug’s efficacy can be impacted by how it is delivered. Therefore, by finding the delivery system that is best suited for a specific medication, it’s possible to optimize the drug within the body. Continuous innovation in the field of drug delivery is enhancing both the effectiveness of treatments and the patient experience across small molecules, biologics, cosmetics, personal care, and nutraceuticals. The combination product market is developing as a result of contemporary technology and medicine. Drug delivery systems are an integral part of the healthcare ecosystem. Patient health outcomes hinge on the precise delivery of medication by the regimen prescribed by medical practitioners. Digital technologies driving connected drug delivery solutions include the Internet of Things (connectivity, remote device monitoring and management, diagnostics, and software patching), Machine Learning (audio-visual input-based device diagnostics and control), and mobility (sensor data, user-focused mobile applications for reporting and engagement, and a feedback loop for providers, payers, and practitioners).

By collecting insights from industry veterans, research experts, and the Drug     Delivery editorial team, we have curated the offerings that matter the most in today’s tough market conditions for the medical sector. Considering the technology and digital transformations of the world’s leading companies and executives, this magazine edition intends to prepare your understanding and readiness for future developments.

We hereby present to you Digital Health’s “Top 10 Drug Delivery Solutions Providers—2022.”

Adare Pharma Solutions

Management:

Tom Sellig

Designation:

CEO

Headquarters:

Lawrenceville, NJ

Website:

adarepharmasolutions.com

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise focusing on oral dosage forms for the Pharmaceutical industry. Adare’s specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions.

Delpor

Management:

Tassos Nicolaou

Designation:

President & CEO

Headquarters:

Brisbane, CA

Website:

delpor.com

Delpor is a clinical stage life sciences company that utilizes innovative drug-delivery technologies in order to develop once-yearly therapies for chronic conditions. The Company’s lead product is a 6-12-month formulation of Risperidone (drug/device combination product) for the treatment of schizophrenia.

Impel Pharmaceuticals

Management:

Adrian Adams

Designation:

Chairman & CEO

Headquarters:

Seattle, WA

Website:

impelpharma.com

Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet medical needs through the pioneering of an optimized approach to drug delivery. The company's therapies have the potential to improve the onset of symptomatic relief for a spectrum of neurological conditions.

INOVIO Pharmaceuticals

Management:

Jacqueline Shea

Designation:

President & CEO

Headquarters:

Plymouth Meeting, PA

Website:

inovio.com

INOVIO Pharmaceuticals, Inc. (INOVIO) is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure and protect people from infectious diseases, cancer and HPV-associated diseases. ​ INOVIO’s DNA medicines platform and proprietary smart device can target virtually any DNA sequence. With 15 clinical programs currently in development, INOVIO has the potential to save and protect lives worldwide and power a new decade of DNA medicines. ​

Kindeva Drug Delivery

Management:

Aaron Mann

Designation:

CEO

Headquarters:

Woodbury, MN

Website:

kindevadd.com

Formerly 3M Drug Delivery Systems, Kindeva (pronounced Kin-dev-uh) is fueled by the same industry experts and offers the same capabilities and technologies—now with unprecedented dedication and flexibility. As a leading CDMO, they partner with you to advance complex drug product programs through their integrated, end-to-end capabilities.

Lyra Therapeutics

Management:

Maria Palasis

Designation:

President & CEO

Headquarters:

Watertown, MA

Website:

Lyratx.com

Creating precisely tuned medicines so patients can breathe freely, we are pioneering a new therapeutic approach to treat debilitating ear, nose and throat diseases that impact the lives of millions of people. Lyra Therapeutics is a clinical-stage company pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.

NEMERA

Management:

Marc Hämel

Designation:

CEO

Headquarters:

La Verpilliere, France

Website:

nemera.net

As a world-leading drug device combination solutions specialist, their purpose of putting patients first enables them to design and manufacture devices that maximize treatment efficacy. They are the utmost holistic partner and help their customers succeed in the sprint to market. From early device strategy to state-of-the-art manufacturing, Nemera is committed to the highest quality standards. Agile and open-minded, they work with their customers as colleagues. Together, they go the extra mile to fulfill their mission.

Slingshot

Management:

Jeff Kim

Designation:

Co-Founder & CEO

Headquarters:

Emeryville, CA

Website:

slingshotbio.com

Slingshot is working on an overlooked but ubiquitous problem in healthcare that has tremendous impact on a variety of patient outcomes: the lack of consistent reference material for cell-based assays. The company’s cell mimics represent a new way to use control material in the workflow. Whether that is for instrument manufacturing, assay set up and validation, or as a manufacturing QC control.

Tapemark

Management:

Beau Garret

Designation:

CEO

Headquarters:

West St. Paul, MN

Website:

tapemark.com

The Tapemark team is powered, staffed, and driven to help clients move faster, better, and with unrivaled quality to benefit the patient and improve compliance. Their pharmaceutical products perform in the clinic and surpass FDA standards. Tapemark is privately-held and based in West St. Paul, Minnesota, with multiple facilities in a campus environment. The company services the pharmaceutical, medical, and consumer products markets.

West Pharmaceutical Services

Management:

Eric M. Green

Designation:

President & CEO

Headquarters:

Exton, PA

Website:

westpharma.com

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year.